A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The main purpose of this study is to evaluate the effect of multiple doses of carbamazepine (a strong inducer of cytochrome P450 \[CYP\]3A4 and a weak inducer of CYP2C9) on the pharmacokinetics of a single oral dose of erdafitinib in healthy adult participants.
Epistemonikos ID: 3a97f8aef76e69dff4832a55429a5af996fbd2e8
First added on: May 07, 2024